anti-vaccine

FDA
Favicon Fierce Pharma

Vaccine makers facing increased volatility, uncertainty at FDA

The FDA's decision to not review Moderna's flu vaccine application is another indication of the volatility and unpredictability of the U.S. regulator.
Kevin Dunleavy Feb 13, 2026 11:12am
three spotlights on a stage

Jay Bhattacharya faces Senate grilling on NIH disruptions

Feb 3, 2026 5:20pm
bacteria and virus science on chalkboard

US vaccine landscape ‘100%’ impacting business: Bancel

Jan 23, 2026 1:26pm
Union Square in San Francisco during JPM 2026

JPM26: Sanofi looks ahead to lingering US policy hurdles

Jan 14, 2026 2:28pm
Jeanne Marrazzo

Fired NIAID director sues health officials, calls ouster illegal

Dec 17, 2025 1:22pm
big wave over ship in storm

mRNA coalition demands stable FDA leadership amid vaccine changes

Dec 5, 2025 1:36pm